HHRN Omnitrope Training
This training will prepare you to conduct in-home injection training visits for Omnitrope patients. You must take this training and pass the post-test with a score of 100% prior to conducting in-home injection training visits. You may take the training and quiz as many times as necessary to achieve a passing score. Your certification will be valid for one year from the date that you pass the quiz. After reading each slide thoroughly, click the 'Next' button to advance to the next slide in the training module. When you are ready to begin, please click the 'Next' button below to begin the training.
This training will prepare you to conduct in-home injection training visits for Omnitrope patients. You must take this training and pass the post-test with a score of 100% prior to conducting in-home injection training visits. You may take the training and quiz as many times as necessary to achieve a passing score. Your certification will be valid for one year from the date that you pass the quiz. After reading each slide thoroughly, click the 'Next' button to advance to the next slide in the training module. When you are ready to begin, please click the 'Next' button below to begin the training.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Hall JE. Introduction to endocrinology. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:925-937.
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
REFERENCES:
Koeppen BM, Stanton BA. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2018:733-752.
Mehta A, Gevers EF, Dattani MT. Congenital disorders of the hypothalamo-pituitary-somatotrope axis. In: Brook CGD, Clayton PE, Brown RS, eds. Brook’s Clinical Pediatric Endocrinology. 6th ed. Hoboken, NJ: Wiley-Blackwell; 2009:60-105.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
Rhoades RA, Bell DR. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018: 643-659.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
REFERENCES:
Koeppen BM, Stanton BA. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2018:733-752.
Mehta A, Gevers EF, Dattani MT. Congenital disorders of the hypothalamo-pituitary-somatotrope axis. In: Brook CGD, Clayton PE, Brown RS, eds. Brook’s Clinical Pediatric Endocrinology. 6th ed. Hoboken, NJ: Wiley-Blackwell; 2009:60-105.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
Rhoades RA, Bell DR. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018: 643-659.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
4. Stedman's Medical Dictionary [letter C]. 28th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2006:285-491.
5. Koeppen BM. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2010:733-752.
6. Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
4. Stedman's Medical Dictionary [letter C]. 28th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2006:285-491.
5. Koeppen BM. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2010:733-752.
6. Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
REFERENCES:
Koeppen BM, Stanton BA. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2018:733-752.
REFERENCES:
Koeppen BM, Stanton BA. The hypothalamus and pituitary gland. In: Koeppen BM, Stanton BA, eds. Berne & Levy Physiology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2018:733-752.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
Baumann G. Growth hormone and its disorders. In: Becker KL, Bilezikian JP, Bremner WJ, et al, eds. Principles and Practice of Endocrinology and Metabolism 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:129-145.
REFERENCES:
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
REFERENCES:
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
REFERENCES:
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Rhoades RA. Hypothalamus and the pituitary gland. In: Rhoades RA, Bell DR, eds. Medical Physiology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2018:643-659.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
REFERENCES:
Hall JE. Pituitary hormones and their control by the hypothalamus. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:939-950.
Parker KL, Schimmer BP. Introduction to endocrinology: the hypothalamic-pituitary axis. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011:1103-1127.
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
REFERENCES:
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
Lanes R. Growth hormone-deficiency in the adult: transition from adolescence to adulthood. In: Lifshitz F, ed. Pediatric Endocrinology. Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Healthcare; 2007:101-111.
Cohen J, Blethen S, Kuntze J, et al. Managing the child with severe primary insulin-like growth factor-1 deficiency (IGFD): IGFD diagnosis and management. Drugs R D. 2014;14(1):25-29.
REFERENCES:
Rosenbloom A, Connor EL. Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:65-99.
Lanes R. Growth hormone-deficiency in the adult: transition from adolescence to adulthood. In: Lifshitz F, ed. Pediatric Endocrinology. Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Healthcare; 2007:101-111.
Cohen J, Blethen S, Kuntze J, et al. Managing the child with severe primary insulin-like growth factor-1 deficiency (IGFD): IGFD diagnosis and management. Drugs R D. 2014;14(1):25-29.
REFERENCES:
Johannesen J, Cowell CT. Differential diagnosis of short stature and poor growth velocity. In: Wass JAH, Stewart PM, eds. Oxford Textbook of Endocrinology and Diabetes. 2nd ed. New York, NY: Oxford University Press; 2011:1049-1058.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
Wales JK. Evaluation of growth disorders. In: Brook CGD, Clayton PE, Brown RS, eds. Brook's Clinical Pediatric Endocrinology. 6th ed. Hoboken, NJ: Wiley-Blackwell; 2009:124-154.
REFERENCES:
Johannesen J, Cowell CT. Differential diagnosis of short stature and poor growth velocity. In: Wass JAH, Stewart PM, eds. Oxford Textbook of Endocrinology and Diabetes. 2nd ed. New York, NY: Oxford University Press; 2011:1049-1058.
Nathan BM, Allen DB. Growth hormone treatment. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:113-143.
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
Wales JK. Evaluation of growth disorders. In: Brook CGD, Clayton PE, Brown RS, eds. Brook's Clinical Pediatric Endocrinology. 6th ed. Hoboken, NJ: Wiley-Blackwell; 2009:124-154.
REFERENCES:
Stochholm K, Gravholt CH, Laursen T, et al. Incidence of GH deficiency─a nationwide study. Eur J Endocrinol. 2006;155:61-71.
Lanes R. Growth hormone-deficiency in the adult: transition from adolescence to adulthood. In: Lifshitz F, ed. Pediatric Endocrinology. Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Healthcare; 2007:101-111.
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609.
REFERENCES:
Stochholm K, Gravholt CH, Laursen T, et al. Incidence of GH deficiency─a nationwide study. Eur J Endocrinol. 2006;155:61-71.
Lanes R. Growth hormone-deficiency in the adult: transition from adolescence to adulthood. In: Lifshitz F, ed. Pediatric Endocrinology. Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Healthcare; 2007:101-111.
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609.
REFERENCES:
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3-13.
REFERENCES:
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3-13.
REFERENCES:
Lee PA, Chernausek SD, Hokken-Koelega ACS, Czernichow P; for the International SGA Advisory Board. International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of Short Children Born Small for Gestational Age, April 24–October 1, 2001. Pediatrics. 2003;111(6 Pt 1):1253-1261.
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
REFERENCES:
Lee PA, Chernausek SD, Hokken-Koelega ACS, Czernichow P; for the International SGA Advisory Board. International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of Short Children Born Small for Gestational Age, April 24–October 1, 2001. Pediatrics. 2003;111(6 Pt 1):1253-1261.
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
REFERENCES:
Cohen P, Rogol AD, Deal CL, et al; for the 2007 ISS Consensus Workshop Participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210-4217.
Grimberg A, DiVall SA, Polychronakos, et al; on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for growth hormone and insulin-like growth factor-1 treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-1 deficiency. Horm Res Paediatr. 2016;86:361-397.
REFERENCES:
Cohen P, Rogol AD, Deal CL, et al; for the 2007 ISS Consensus Workshop Participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210-4217.
Grimberg A, DiVall SA, Polychronakos, et al; on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for growth hormone and insulin-like growth factor-1 treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-1 deficiency. Horm Res Paediatr. 2016;86:361-397.
REFERENCES:
Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95(4):1487-1495.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95(4):1487-1495.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
REFERENCES:
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
GH Research Society. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85(11):3990-3993.
REFERENCES:
Grimberg A, Lifshitz F. Worrisome growth. In: Lifshitz F, ed. Pediatric Endocrinology Volume 2: Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders. 5th ed. New York, NY: Informa Health; 2007:1-50.
Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of insulin-like growth hormone/growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014:292-404.
GH Research Society. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85(11):3990-3993.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
REFERENCES:
OMNITROPE® (somatropin) injection, for subcutaneous use [package insert]. Princeton, NJ: Sandoz Inc; December 2016.
Omnitrope is a registered trademark of Novartis AG.
Genotropin is a registered trademark of Pfizer Inc.
©2017 Sandoz Inc.
100 College Road West, Princeton, NJ 08540
All rights reserved.
S-OMN-1349879 10/2017
Omnitrope is a registered trademark of Novartis AG.
Genotropin is a registered trademark of Pfizer Inc.
©2017 Sandoz Inc.
100 College Road West, Princeton, NJ 08540
All rights reserved.
S-OMN-1349879 10/2017
Now that you have viewed the training, click 'Next' to begin the quiz. The quiz consists of 13 questions and you must achieve a score of 13/13 (100%) to pass. There is only ONE correct answer for each question. If you do not achieve a passing score the first time, you may re-take the training and the quiz as many times as necessary to pass the quiz. You must pass the quiz before performing any in-home teach and train sessions.
Now that you have viewed the training, click 'Next' to begin the quiz. The quiz consists of 13 questions and you must achieve a score of 13/13 (100%) to pass. There is only ONE correct answer for each question. If you do not achieve a passing score the first time, you may re-take the training and the quiz as many times as necessary to pass the quiz. You must pass the quiz before performing any in-home teach and train sessions.
Growth hormone (GH) is secreted by the _________________________.
anterior lobe of the pituitary gland
posterior lobe of the pituitary gland
hypothalamus
thyroid gland
When do the highest peaks in growth hormone (GH) typically occur?
Within 30 minutes of falling asleep
During the first 2 hours of deep sleep
3 hours after falling asleep
After 4 hours of deep sleep
What hormones stimulate the secretion of growth hormone (GH)?
Growth hormone-releasing hormone (GHRH) and ghrelin
Somatostatin and growth hormone-releasing hormone (GHRH)
Somatomedins (insulin-like growth factors [IGFs]) and ghrelin
Somatostatin and somatomedins (insulin-like growth factors [IGFs])
Congenital growth hormone (GH) deficiency differs from acquired GH deficiency in that it __________________________________.
is a complication of central nervous system (CNS) infection
can be caused by trauma or autoimmune diseases
results due to structural malformations of the brain
develops after birth
Which of the following growth disorders is characterized by hypotonia and failure to thrive in the postnatal period, as well as short stature, cognitive disabilities, hyperphagia, and obesity following the postnatal period?
Turner syndrome (TS)
Prader-Willi syndrome (PWS)
Idiopathic short stature (ISS)
Small for gestational age (SGA)
All of the following are part of the diagnosis of growth hormone deficiency (GHD) and growth hormone disorders except for what?
Physical examination
Growth hormone (GH) stimulation tests
Laboratory studies
Ultrasound/sonography
What is the recommended dosage of OMNITROPE® for the treatment of pediatric growth hormone deficiency (GHD)?
0.16 to 0.24 mg/kg body weight per week divided over 6 or 7 days of subcutaneous injections
0.24 mg/kg/day
0.33 mg/kg/week in divided doses given on 3 alternate days, 6 times per week, or daily
0.5 mg/kg/day
The use of OMNITROPE® is contraindicated in patients with ______________.
pancreatitis
fluid retention
active malignancy
lipoatrophy
The following topic is listed as a warning/precaution in the OMNITROPE® label because it has been associated with serious adverse events and death, particularly in pediatric patients (ie, “gasping syndrome”).
Prader-Willi syndrome (PWS) in children
Neoplasms
Hypersensitivity
Benzyl alcohol
Which of the following is NOT a responsibility of the registered nurse (RN)?
Confirm that the pen/vial education checklist is correct and complete post-visit
Administer the medication to show the proper dose and technique
Provide side-by-side instruction to the patient/caregiver on injection administration
Complete the pre-scheduling checklist prior to contacting patients
Copy and paste this link and scroll down to watch the pen device video.
Once you have viewed the entire video, please answer the question below.
Have you watched the entire video?
Yes
No
Copy and paste the below link. Once you get to the website scroll down and watch the vial video.
https://www.omnitrope.com/your-omnisource/injection-training#
Once you have viewed the entire video, please answer the question below.
Have you watched the entire video?
Yes
No
{"name":"HHRN Omnitrope Training", "url":"https://www.quiz-maker.com/Q7ZJEDU","txt":"This training will prepare you to conduct in-home teach and train visits for Omnitrope patients. You must take this training and pass the post-test with a score of 100% prior to conducting in-home teach and train visits. You may take the training and quiz as many times as necessary to achieve a passing score. After reading each slide thoroughly, click the 'Next' button to advance to the next slide in the training module. When you are ready to begin, please click the 'Next' button below to begin the training.","img":"https://cdn.poll-maker.com/23-876750/slide1.jpg?sz=1200"}
